News

Study Finds on MSN1d
Weight Loss Showdown: Mounjaro (Tirzepatide) Trounces Wegovy in Head-to-Head Trial
In a nutshell Tirzepatide (Mounjaro) produced 20.2% weight loss compared to semaglutide’s (Wegovy) 13.7% after 72 weeks of ...
This Drug Is Nearly 50 Percent More Effective Than Wegovy
A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s ...
MedPage Today on MSN1d
Zepbound and Wegovy Go Head to Head for Obesity: And the Winner Is ...
Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...
Zepbound outperforms Wegovy in head-to-head weight loss study
A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo ...
This drug led to 50% more weight loss than Wegovy in head-to-head study
While the drugs certainly contribute to weight loss and health gains, they also cause a decline in muscle that some doctors ...
Eli Lilly’s Zepbound shows superior weight loss over Novo Nordisk's Wegovy in trial
Eli Lilly ( NYSE: LLY) on Sunday said that its drug Zepbound (tirzepatide) showed superior weight loss over Novo Nordisk's ( ...
Healio10h
Tirzepatide bests semaglutide for weight loss in adults with obesity
Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...
The Print on MSN22h
Mounjaro vs Wegovy: Guess which obesity drug outperformed the other by a mile in head-to-head trial
Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...
News-Medical.Net on MSN1d
Tirzepatide outperforms semaglutide in weight loss clinical trial
Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...